Tagged with HE

Taiwan In an exclusive interview conducted on the 22nd of December 2016, Taiwan’s Minister of Health and Welfare Lin Tzou-yien discussed improving Taiwan’s National Health Insurance (NHI), ensuring that Taiwanese patients can access innovative treatments, and nurturing the development of Taiwan’s thriving R&D-driven pharmaceutical and biotech industries. Minister Lin, you became…

France In an exclusive interview, Agnès Buzyn, Chairwoman of the Board for the French National Authority for Health (Haute Autorité de Santé – HAS), on her organization’s priorities, the particularities of the French healthcare system, and what can be learned from other countries’ systems. Your career includes experiences as a doctor,…

Mexico María Teresa Lopez, managing director at Zimmer Biomet Mexico, discusses the medtech company’s strong commitment to Mexico as well as the high added value of its broad and innovative health solutions to enhance patients’ quality of life. Please introduce the main activities of Zimmer Biomet in Mexico and the Mexican…

USA Take our poll on Donald Trump and Pharma at the bottom of the article Speaking at a White House meeting with senior pharmaceutical executives, US President Donald Trump told drug companies to lower their “astronomical” prices. He pledged to curb regulations and lower tax rates to allow companies to do so,…

Pharma Over the past year, PharmaBoardroom has spoken to many of the global leaders in healthcare logistics from regions as diverse as France, Mexico, Luxembourg, and Singapore. As pharmaceutical and biotech products become more complex and the markets they serve become more diverse; these industry leaders have told us how their…

Singapore The Big Picture Singapore’s real GDP per person has grown incredibly since independence in 1965, helping the country make the leap from third world to first world in less than half a century. Switzerland is the world’s leading nation for investor friendliness in terms of ease of doing business, labour…

Switzerland The Services Delivery Director for Life Sciences of NNIT Switzerland talks big data and highlights how this trend needs to be approached in order to create value for companies in the life science industry. You first joined NNIT in 2010; you then moved to the FMCG sector for a few…

Mexico Alberto Wicker, CEO at Signufarma, explains how patient compliance programs can enhance the national healthcare system through reducing the cost of treatment as well as improving patients’ quality of life and showcases the added value of Signufarma’s business solutions to enhance the medical compliance of Mexican patients. Could you please…

Switzerland Daniel Schmutz, CEO of Switzerland’s leading insurance company, Helsana, sketches out the Swiss health insurance landscape, how his company maintains its market leader position, and working with both national and international partners to create better products for its customers and a more efficient insurance system. With 1.9 million policy takers…

Switzerland LEO Pharma’s Country Lead for Switzerland, Patrick Brunner, discusses the skincare specialist’s most important products, the Swiss affiliate’s significance to the global group, and the exciting new partnership with AstraZeneca. LEO Pharma Switzerland was established back in 1991 meaning that, last year, you celebrated 25 years of in-country operations. Could…

Greece A strong proponent of the value of orphan drugs, Shire Greece’s Managing Director, Christos Dakas, shares his insights on the recent merger with Baxalta, the necessity of exempting orphan and haemophilia drugs from clawbacks to circumvent market challenges for critical treatments, as well as his vision for the bright future…

Singapore Coming from DHL’s Customer Solutions & Innovation division, Leonora Lim, Vice President Life Sciences & Healthcare Asia Pacific, gives an insight into the increasingly demanding logistics needs of pharmaceutical clients and how DHL’s investments in the life sciences and healthcare sector have kept the company a step ahead.   The…